Listed

Akso Health Group: Form 20-F for the period ended Mar 31, 2024

Filed with the SEC on Jul 30, 2024 and accepted by EDGAR at Jul 30, 2024, 16:05 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2023-04-01 to 2024-03-31$2.4mus-gaap:Revenues
Gross profit12 months2023-04-01 to 2024-03-31$122.1kus-gaap:GrossProfit
Operating income12 months2023-04-01 to 2024-03-31−$8.6mus-gaap:OperatingIncomeLoss
Income tax12 months2023-04-01 to 2024-03-31$25.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2023-04-01 to 2024-03-31−$9.5mus-gaap:NetIncomeLoss
Diluted EPS12 months2023-04-01 to 2024-03-31−$0.07us-gaap:EarningsPerShareDiluted
Basic EPS12 months2023-04-01 to 2024-03-31−$0.07us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2023-04-01 to 2024-03-31141,516,777 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2023-04-01 to 2024-03-31$1.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2024-03-31$85.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-03-31$142.0mus-gaap:AssetsCurrent
Total assetsAt period end2024-03-31$142.0mus-gaap:Assets
Current liabilitiesAt period end2024-03-31$3.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-03-31$3.6mus-gaap:Liabilities
Shareholders' equityAt period end2024-03-31$138.4mus-gaap:StockholdersEquity
Shares outstandingAt period end2024-03-31437,170,960 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001013762-24-002658. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.